About Event
Join the 6th Cytokine-Based Drug Development Summit to Collaborate & Connect with 70+ CxOs, VPs, Directors & Scientists to help Deliver Life-Changing Therapies to Patients
The 6th Cytokine-Based Drug Development Summit returns as the only industry-focused conference that provides practical knowledge, reflective lessons, and innovative approaches to overcome challenges with cytokine drug development. The Summit provides a unique opportunity for the exchange of information and networking in this field - all geared to assisting with the successful progression of your candidate into and through the clinic.
With a focus on the immunoregulatory role that cytokine-based drugs play in disease, join us to explore how engineered cytokine drugs and novel approaches can widen the therapeutic window and maximise the translation of your cytokine-associated toxicities. Join preclinical experts to explore the challenges with interleukins (IL-2, IL-6, IL-10, IL-12, IL-18), interferons, cytokine mimetics, and toxicities, such as cytokine release syndrome (CRS).
Gain exclusive insights into the latest advancements in the understanding and application of preclinical models, and the biology and potential role of synthetic cytokines and cytokine-based drugs in the treatment of oncology and inflammatory diseases.
Who Will You Meet?
Conference Highlights Included:
Discover effective approaches to overcome key toxicity challenges in cytokine-based therapies, such as their short half-lives and high receptor affinity. Learn about innovative strategies and immune system modulation to reduce toxicity and enhance safety profiles, with insights from Sanofi and Sonnet Biotherapeutics as we shift our focus to Immunology and Inflammation as well as Oncology
Dive into novel masking techniques employed by industry leaders like Candel Therapeutics, Regeneron, OSE Immunotherapeutics, and Werewolf Therapeutics to improve specificity, boost delivery, and minimize toxicity in cytokine therapies
Explore the challenges of using animal models in cytokine-based therapies. Assess the limitations of current models and discover how ModeX and Synthekine are advancing the field to improve translational relevance, enhancing the likelihood of clinical success
Gain insight into the global factors contributing to clinical failures in cytokine-based therapies. By understanding the root causes of these setbacks and leveraging emerging trends, you’ll be better positioned to identify promising research areas and maximize the potential for successful cytokine therapies, with guidance from Beacon
